Fennec Pharmaceuticals (FRX) Stock Chart & Stock Price History C$11.67 -0.25 (-2.10%) As of 07/15/2025 01:10 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesBuy This Stock Fennec Pharmaceuticals Stock Price Performance The Fennec Pharmaceuticals (FRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 27.54%, with a year-to-date return of 31.57%. In the past month, the stock has increased 5.04%, reflecting recent market activity. As of the latest close, Fennec Pharmaceuticals traded at C$11.67 with a market cap of C$225.05 million and volume of 100 shares. Five years ago, the stock traded at C$12.80, representing a 8.83% decrease over that period. At the time, it had a market cap of C$274.86 million and a volume of 4,057 shares. Receive FRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-3.55%1 Month Performance+5.04%3 Month Performance+53.96%Year-To-Date Performance+31.57%1 Year Performance+27.54%5 Year Performance-8.83% FRX Stock Chart for Wednesday, July, 16, 2025 FRX Chart by TradingView Fennec Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/15/2025C$11.92C$11.67-2.10%C$11.67C$11.67100 shsC$225.05 million07/14/2025C$12.10C$11.92-1.49%C$12.05C$11.92202 shsC$229.87 million07/11/2025C$12.50C$12.10-3.20%C$12.99C$12.101,582 shsC$233.35 million07/10/2025C$11.89C$12.50+5.13%C$12.50C$12.121,188 shsC$241.06 million07/09/2025C$11.89C$11.89C$11.89C$11.89200 shsC$229.30 million07/08/2025C$11.62C$11.89+2.32%C$11.89C$11.89200 shsC$229.30 million07/07/2025C$12.16C$11.62-4.44%C$11.86C$11.621,243 shsC$224.09 million07/04/2025C$11.89C$12.16+2.27%C$12.16C$12.141,210 shsC$234.50 million07/03/2025C$11.69C$11.89+1.71%C$11.90C$11.69902 shsC$229.30 million07/02/2025C$11.29C$11.69+3.54%C$11.69C$11.64216 shsC$225.44 million Get the Latest News and Ratings for FRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/01/2025C$11.29C$11.29C$11.29C$11.002,711 shsC$217.72 million06/30/2025C$11.29C$11.29C$11.29C$11.002,711 shsC$217.72 million06/27/2025C$11.33C$11.29-0.35%C$11.29C$11.002,711 shsC$217.72 million06/26/2025C$11.81C$11.33-4.06%C$11.34C$11.33200 shsC$218.50 million06/25/2025C$11.56C$11.81+2.16%C$11.81C$11.311,101 shsC$227.75 million06/24/2025C$10.77C$11.56+7.34%C$11.56C$10.992,588 shsC$222.93 million06/23/2025C$10.77C$10.77C$10.77C$10.61200 shsC$207.70 million06/20/2025C$10.66C$10.77+1.03%C$11.38C$10.77400 shsC$207.70 million06/19/2025C$10.66C$10.66C$10.66C$10.57300 shsC$205.58 million06/18/2025C$10.45C$10.66+2.01%C$10.66C$10.57300 shsC$205.58 million06/17/2025C$11.11C$10.45-5.94%C$10.82C$10.451,520 shsC$201.53 million06/16/2025C$10.76C$11.11+3.25%C$11.11C$10.85700 shsC$214.25 million Related Companies SLS Stock Chart CRON Stock Chart TLRY Stock Chart AIM Stock Chart ITH Stock Chart CRDL Stock Chart GXE Stock Chart EQ Stock Chart GPH Stock Chart MDNA Stock Chart Receive FRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:FRX) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredMajor Rollout of Social Security X?To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredThe Next Commodity Crisis Just Got a Name: SilverElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fennec Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fennec Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
